OVERVIEW

Community Practice Connections™: The Evolving Treatment Landscape for Patients With Graft-versus-Host Disease (GvHD): More Options, More Decisions, Better Outcomes! is organized by Physicians' Education Resource, LLC (PER).

Release Date: January 31, 2020
Expiration Date: January 31, 2021

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
Community Practice Connections™: The Evolving Treatment Landscape for Patients With GvHD: More Options, More Decisions, Better Outcomes! consists of a series of short video interviews of leading experts in allogeneic hematopoietic transplantation, and brief summaries of recent clinical data with a focus on the newest approvals for treating graft-versus-host disease (GvHD). The video interviews address questions commonly faced in the community oncology practice setting.

Benefits of Participating:
• Hear experts talk about emerging therapies for GvHD
• Gain insights regarding GvHD prophylaxis
• Learn about algorithms for stratifying risk in GvHD
• Obtain insight into survivorship care

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Identify recent advances regarding understanding of the biology of GvHD, with the potential to improve the ability to predict GvHD occurrence and plan treatment strategies
• Evaluate recent clinical trial data regarding emerging treatment strategies for acute and chronic GvHD
• Outline current and emerging prophylactic strategies for the prevention of GvHD onset
• Integrate emerging options for prophylaxis and management into plans of care for patients at risk of developing GvHD

Credits
  • 2 CME
  • SPECIALITIES

    Emergency Medicine

    RELATED ONLINE COURSES

    By Provider Practice Essentials...

    Webcast

    State required course for Illinois ...
    70 CME/CE
    More actions
    US$125